Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kymera Therapeutics (KYMR) Change in Cash (2019 - 2026)

Kymera Therapeutics (KYMR) has disclosed Change in Cash for 8 consecutive years, with -$212.9 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Cash fell 603.21% year-over-year to -$212.9 million; the TTM value through Mar 2026 reached $54.1 million, up 1619.57%, while the annual FY2025 figure was $236.8 million, 2204.69% up from the prior year.
  • Change in Cash hit -$212.9 million in Q1 2026 for Kymera Therapeutics, down from $244.1 million in the prior quarter.
  • Across five years, Change in Cash topped out at $245.9 million in Q2 2025 and bottomed at -$222.9 million in Q3 2025.
  • Average Change in Cash over 5 years is $5.6 million, with a median of $1.9 million recorded in 2023.
  • Year-over-year, Change in Cash tumbled 1470.87% in 2024 and then soared 2456.02% in 2025.
  • Kymera Therapeutics' Change in Cash stood at -$87.2 million in 2022, then soared by 133.16% to $28.9 million in 2023, then tumbled by 66.99% to $9.5 million in 2024, then skyrocketed by 2456.02% to $244.1 million in 2025, then crashed by 187.23% to -$212.9 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$212.9 million, $244.1 million, and -$222.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.